These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5380778)

  • 21. Cephalosporin therapy of urinary tract infections.
    Cox CE; Montgomery WG
    Postgrad Med J; 1971 Feb; 47():Suppl:107-18. PubMed ID: 5556182
    [No Abstract]   [Full Text] [Related]  

  • 22. Excretion of cephaloridine and cephalothin in patients with renal impairment.
    Kunin CM; Atuk N
    N Engl J Med; 1966 Mar; 274(12):654-6. PubMed ID: 17926378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cephaloridine clinical trial in gram-positive and gram-negative infections.
    Brayton RG; MacLean RA; Louria DB
    Antimicrob Agents Chemother (Bethesda); 1966; 6():96-100. PubMed ID: 5985311
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experiences with combined cephalothin-gentamicin therapy in severe urologic infections].
    Hofstetter A
    Adv Clin Pharmacol; 1974; 8():51-3. PubMed ID: 4468730
    [No Abstract]   [Full Text] [Related]  

  • 25. Cephaloridine versus cephalothin: relation of the kidney to blood level differences after parenteral administration.
    Tuano SB; Brodie JL; Kirby WM
    Antimicrob Agents Chemother (Bethesda); 1966; 6():101-6. PubMed ID: 5985234
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathogenesis of meningitis. VIII. Cerebrospinal fluid and blood concentrations of methicillin, cephalothin, and cephaloridine in experimental pneumococcal meningitis.
    Oppenheimer S; Beaty HN; Petersdorf RG
    J Lab Clin Med; 1969 Apr; 73(4):535-43. PubMed ID: 5775125
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cephalothin for discontinuous venous infusion in urology. Practical note].
    Comeri G; Passera R
    Minerva Urol; 1973; 25(2):90-6. PubMed ID: 4575480
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experimental studies on the topical antibiotic treatment for the lower urinary infection].
    Kageyama T
    Hinyokika Kiyo; 1971 Apr; 17(4):225-35. PubMed ID: 5165317
    [No Abstract]   [Full Text] [Related]  

  • 29. Cephaloridine and cephalothin: comparative studies of potential nephrotoxicity.
    Perkins RL; Apicella MA; Lee IS; Cuppage FE; Saslaw S
    J Lab Clin Med; 1968 Jan; 71(1):75-84. PubMed ID: 4965437
    [No Abstract]   [Full Text] [Related]  

  • 30. Cephalothin and cephaloridine: comparative pharmacodynamics in chronic uremia.
    Perkins RL; Smith EJ; Saslaw S
    Am J Med Sci; 1969 Feb; 257(2):116-24. PubMed ID: 4974464
    [No Abstract]   [Full Text] [Related]  

  • 31. Cephaloglycin in urinary-tract infections.
    Seneca H; Zinsser HH; Peer P
    J Am Geriatr Soc; 1970 Jun; 18(6):433-42. PubMed ID: 5446054
    [No Abstract]   [Full Text] [Related]  

  • 32. Cephalothin and hemolytic anemia.
    Swanson M
    Ann Intern Med; 1970 Dec; 73(6):1046. PubMed ID: 5525539
    [No Abstract]   [Full Text] [Related]  

  • 33. [The Nebicin-Keflin combination in complicated urological infections].
    Marascia G; Magnocavallo N; Gaspari G; Berardi D; Petrone U
    Minerva Urol; 1982; 34(1):59-62. PubMed ID: 7087944
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cephaloridine, a new semi-synthetic cephalosporin. Clinical use].
    Brogard JM; Kuntzmann F; Tulasne R; Stahl J
    Presse Med (1893); 1968 May; 76(26):1281-2. PubMed ID: 4873123
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical evaluation of cefotiam (CGP/14221) versus cephalothin in the treatment of urinary tract infections.
    Tselentis J; Cordossis T; Eliopoulos G
    Pharmatherapeutica; 1983; 3(6):382-7. PubMed ID: 6312460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rate of binding of antibiotics to canine serum protein.
    Waterman N; Scharfenberger L; Raff MJ
    Antimicrob Agents Chemother; 1974 Mar; 5(3):294-5. PubMed ID: 4840437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cephaloridine, a new antibiotic.
    Stratford BC; Dixson S
    Med J Aust; 1968 Jun; 1(26):1114-20. PubMed ID: 4875336
    [No Abstract]   [Full Text] [Related]  

  • 38. Absence of nephrotoxicity during cephaloridine therapy.
    McAllister TA
    Lancet; 1972 Sep; 2(7779):710. PubMed ID: 4115843
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of cephaloridine in urinary tract infections].
    Ohori T; Koshiba K; Yoshida I; Kira M; Yoda S
    Hinyokika Kiyo; 1967 Mar; 13(3):249-53. PubMed ID: 6070888
    [No Abstract]   [Full Text] [Related]  

  • 40. [Laboratory and clinical evaluation of cephalosporin C preparations. 3. Cephalothin sensitivity test by disc method and intravenous injection therapy].
    Kanazawa Y; Kuramata T
    Jpn J Antibiot; 1968 Feb; 21(1):1-9. PubMed ID: 5302100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.